Novartis AG (NVSEF) stock

NVSEFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVS

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30

$146.46+2.56 (+1.78%)

Close on Oct 19, 2026Market cap $279.46BP/E 20.5Yield –

Novartis ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Novartis has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?